Role of Hydrogen Sulfide in Colorectal Tumors
Role of Hydrogen Sulfide in Colorectal Tumors
批准号:
9079450
负责人:
MARK R HELLMICH
金额:
$31.26万
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-06-19 至 2019-05-31
关键词:
3-Mercaptopyruvate sulfurtransferaseAddressAminooxyacetic AcidAnimal ModelAnimalsAntineoplastic AgentsApoptosisApplications GrantsAreaBioenergeticsBiologicalBiological ProcessBiological Response Modifier TherapyCancer BiologyCancer PatientCancer cell lineCecumCell LineCell ProliferationCellsCharacteristicsClinicalClinical TrialsColon CarcinomaColorectal CancerColorectal NeoplasmsComplexCystathionineDataDevelopmentElectron TransportElectronsEnzymesEpigenetic ProcessEquilibriumFoundationsGOT2 geneGasesGenerationsGeneticGlycolysisGrowthHealthHeterotopic TransplantationHumanHuman BiologyHydrogen SulfideImmuneIn VitroInflammatoryKRAS2 geneMalate-Aspartate Shuttle PathwayMediatingMediator of activation proteinMitochondriaModelingMolecularMovementMusNADHNeoplasm MetastasisOutcomeOxidative PhosphorylationPTEN genePathway interactionsPatientsPhenotypePhosphotransferasesPost-Translational Protein ProcessingPre-Clinical ModelProductionProteinsPublishingRoleSeriesSignal TransductionTestingTherapeuticTherapeutic AgentsTumor AngiogenesisTumor Cell InvasionTumor Cell MigrationTumor TissueUp-RegulationWorkXenograft ModelXenograft procedureaerobic glycolysisangiogenesisanti-cancer therapeuticbasecancer cellcancer therapycell growthcell motilitycolon cancer cell linedrug developmentdrug efficacyelectron donorextracellularhuman tissuein vivoinhibitor/antagonistinnovationmalignant colon tumormetastatic colorectalmigrationmutational statusneoplastic cellnovelnovel therapeuticsparacrinepre-clinicalresearch studysmall hairpin RNAsubcutaneoussulfhydrationtheoriestranslational studytumortumor growthtumor progressiontumor xenograft
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): This revised grant application focuses on the role of the endogenous gaseous biological mediator hydrogen sulfide (H2S) in colorectal cancer. Based on multiple lines of novel data, we have developed the novel hypothesis that selective upregulation of cystathionine-�-synthase (CBS) and the subsequent production of H2S in colonic cancer cells serves as a pro-survival factor by stimulating tumor cell bioenergetics, growth, proliferation, migration and invasion. In order to explore this concept, we will pursue the
following Aims: #1. To characterize the molecular mechanisms by which the CBS/H2S axis promotes tumor cell bioenergetics and tumor cell proliferation; #2. To determine the molecular mechanisms by which the CBS/H2S axis promotes tumor cell migration, invasion and metastasis; and #3. To evaluate the effect of the CBS inhibitor aminooxyacetic acid (AOAA) in human colorectal cancer, in a translationally relevant animal model utilizing patient-derived xenografts (PDTX) in combination with current clinical anticancer therapeutic agents. Taken together, the current project will utilize human colonic cancer tissues, human colonic cancer cell lines and tumor-bearing mice subjected to heterotopic transplantation of human colon cancer lines or patient-derived xenografts. To address the role of CBS, a combination of genetic (CBS silencing) and pharmacological (CBS inhibitors) approaches will be used. Outcome variables will include parameters of bioenergetics (oxidative phosphorylation, mitochondrial electron transport, glycolysis, GAPDH activity), cell proliferation, cell growth (including activation of pr-inflammatory/pro-growth kinase pathways), tumor cell migration, tumor cell invasion, angiogenesis and metastasis in vitro and in vivo. The role of sulfhydration (a specific H2S-mediated posttranslational protein modification) will be also explored on relevant protein targets (GAPDH, PTEN, PI3K). The final, translational aim will contain studies of potential therapeutic relevance, by testing the anticancer effect of CBS inhibitors, in summary, the current project entails a comprehensive approach to test the importance of CBS/H2S a novel pathway in colorectal cancer, and incorporates early translational work to explore its potential utility as a target for anticancer therapy.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
UTMB Clinical and Translational Science Award
-
批准号:9270638
-
项目类别:
-
资助金额:$26.18万
-
财政年份:2015
-
负责人:MARK R HELLMICH
-
依托单位:
NRSA Training Core
-
批准号:10101759
-
项目类别:
-
资助金额:$36.4万
-
财政年份:2015
-
负责人:MARK R HELLMICH
-
依托单位:
UTMB Clinical and Translational Science Award
-
批准号:9128785
-
项目类别:
-
资助金额:$33.5万
-
财政年份:2015
-
负责人:MARK R HELLMICH
-
依托单位:
UTMB Clinical and Translational Science Award
-
批准号:9085702
-
项目类别:
-
资助金额:$32.66万
-
财政年份:2015
-
负责人:MARK R HELLMICH
-
依托单位:
Role of Hydrogen Sulfide in Colorectal Tumors
-
批准号:8708260
-
项目类别:
-
资助金额:$31.24万
-
财政年份:2014
-
负责人:MARK R HELLMICH
-
依托单位:
CORE--PEPTIDE RECEPTOR CORE LABORATORY
-
批准号:6907132
-
项目类别:
-
资助金额:$14.33万
-
财政年份:2005
-
负责人:MARK R HELLMICH
-
依托单位:
Studies of a Novel CCK-B/Gastrin Receptor Splice Variant
-
批准号:6896603
-
项目类别:
-
资助金额:$27.79万
-
财政年份:2001
-
负责人:MARK R HELLMICH
-
依托单位:
Studies of a Novel CCK-B/Gastrin Receptor Splice Variant
-
批准号:6332317
-
项目类别:
-
资助金额:$25.95万
-
财政年份:2001
-
负责人:MARK R HELLMICH
-
依托单位:
Studies of a Novel CCK-B/Gastrin Receptor Splice Variant
-
批准号:6752509
-
项目类别:
-
资助金额:$26.98万
-
财政年份:2001
-
负责人:MARK R HELLMICH
-
依托单位:
Studies of a Novel CCK-B/Gastrin Receptor Splice Variant
-
批准号:6517796
-
项目类别:
-
资助金额:$25.43万
-
财政年份:2001
-
负责人:MARK R HELLMICH
-
依托单位:
Studies of a Novel CCK-B/Gastrin Receptor Splice Variant
-
批准号:6635297
-
项目类别:
-
资助金额:$26.82万
-
财政年份:2001
-
负责人:MARK R HELLMICH
-
依托单位:
Surgical Studies of GI Peptides - Mechanisms of Action
-
批准号:7271237
-
项目类别:
-
资助金额:$46.7万
-
财政年份:1994
-
负责人:MARK R HELLMICH
-
依托单位:
Surgical Studies of GI Peptides - Mechanisms of Action
-
批准号:7834628
-
项目类别:
-
资助金额:$46.7万
-
财政年份:1994
-
负责人:MARK R HELLMICH
-
依托单位:
Surgical Research Training in Gastrointestinal Diseases
-
批准号:9320839
-
项目类别:
-
资助金额:$20.92万
-
财政年份:1992
-
负责人:MARK R HELLMICH
-
依托单位:
Surgical Research Training in Gastroiontestinal Disease
-
批准号:7901057
-
项目类别:
-
资助金额:$10.73万
-
财政年份:1992
-
负责人:MARK R HELLMICH
-
依托单位:
Surgical Research Training in Gastroiontestinal Disease
-
批准号:7630399
-
项目类别:
-
资助金额:$12.8万
-
财政年份:1992
-
负责人:MARK R HELLMICH
-
依托单位:
Surgical Research Training in Gastrointestinal Diseases
-
批准号:8475293
-
项目类别:
-
资助金额:$18.32万
-
财政年份:1992
-
负责人:MARK R HELLMICH
-
依托单位:
Surgical Research Training in Gastroiontestinal Disease
-
批准号:8302440
-
项目类别:
-
资助金额:$2.37万
-
财政年份:1992
-
负责人:MARK R HELLMICH
-
依托单位:
Surgical Research Training in Gastrointestinal Diseases
-
批准号:8691784
-
项目类别:
-
资助金额:$19.27万
-
财政年份:1992
-
负责人:MARK R HELLMICH
-
依托单位:
Surgical Research Training in Gastrointestinal Diseases
-
批准号:8879283
-
项目类别:
-
资助金额:$6.42万
-
财政年份:1992
-
负责人:MARK R HELLMICH
-
依托单位:
海外基金